Thirty years of esophageal cancer surgery in Oulu University Hospital

• Main Authors: Saviaro, H. (Henna), Rintala, J. (Jukka), Kauppila, J. H. (Joonas H.), Yannopoulos, F. (Fredrik), Meriläinen, S. (Sanna), Koivukangas, V. (Vesa), Huhta, H. (Heikki), Helminen, O. (Olli), Saarnio, J. (Juha)
• Format: Article in Journal/Newspaper
• Language: English
• Published: AME Publishing Company 2021
• Subjects: esophageal cancer; esophagectomy; minimally invasive surgery; McKeown; Northern Finland
• Online Access: http://urn.fi/urn:nbn:fi-fe2021102752480

Abstract Background: Esophagectomy is the mainstay of surgical treatment of esophageal cancer, but involves high operative risk. The aim of this study was to review the evolution surgical treatment of esophageal cancer in Northern Finland, with introduction of minimally invasive techniques. Methods: All elective esophagectomies performed in Oulu University Hospital between years 1987 and 2020 were included. Treatment strategies were compared to current guidelines including staging and use of neoadjuvant therapy, and benchmark values including postoperative morbidity, hospital stay, readmissions and 90-day mortality. Long-term survival was compared to previous national studies. Results: Between years 1987 and 2020 a total of 341 underwent an esophagectomy. Transhiatal resection was performed to 167 (49.3%), Ivor Lewis to 129 (38.1%) and McKeown to 42 (12.4%) patients. MIE was performed to 49 (14.5%) patients. During the past four years 83.7% of locally advanced diseases received neoadjuvant treatment. Since 1987, gradual improvements have occurred especially in incidence of pleural effusion requiring additional drainage procedure (highest in 2011–2013 and in last four years 14.0%), recurrent nerve injuries (highest in 2008–2010 29.4% and lowest in 2017–2020 1.8%) and in 1-year survival rate (1987–1998 68.4% vs. 2017–2020 82.1%). No major changes in comorbidity, complication rate, anastomosis leaks, hospital stay or postoperative mortality were seen. Conclusions: Esophageal cancer surgery has gone through major changes over three decades. Current guideline-based treatment has resulted with progressive improvement in mid- and long-term survival. However, despite modern protocol, no major improvement has occurred for example in major complications, anastomosis leak rates or hospital stay.